
FDA Approves First New Drug Developed for Women with Postpartum Depression
The new drug, Zulresso, can work in days, not the weeks it takes for current treatments
The new drug, Zulresso, can work in days, not the weeks it takes for current treatments
Medical researcher Steffanie Strathdee needed to save the life of her husband, researcher Tom Patterson, when he contracted one of the world's worst infections. She turned to phage therapy: using a virus to kill the bacteria...
Thyroid hormone, which helps warm-blooded animals regulate body temperature, also appears to put a halt on heart regeneration. Christopher Intagliata reports.
Nasal spray related to the anesthetic/street drug ketamine targets treatment-resistant patients
10 years after the so-called “Berlin Patient,” a second man has been put into sustained remission
For the best minds to solve some of medicine’s biggest problems, the right environment can make a big difference
Johnson & Johnson has submitted its esketamine for regulatory approval, but researchers still don't understand how the fast-acting antidepressant lifts moods
Biology at the center of last year’s contentious gene-edited twins result may hold other benefits for brain injury
A study shows the power of the “argument dilution effect”
Plasma from young people offers “no proven clinical benefit” as a treatment against aging or Alzheimer’s disease, the agency says
A tortoise and a puffer fish inspire technology to overcome the multibillion-dollar nonadherence problem
Killing ticks and inoculating people has failed, so researchers try immunizing mice via vaccine-laced food
Promoters hope efforts will also offer insights into treatments used for humans
The World Health Organization predicts the Democratic Republic of the Congo has enough of the experimental vaccine
Data visualization reveals how much hospitals across the nation charge for some of the most common procedures
Changes in brain cells’ DNA may be responsible—and if so, medicines already developed for other diseases might be used to treat it
Scientists are working to correct a genetic defect in cystic fibrosis patients by having them inhale RNA. Christopher Intagliata reports.
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account